Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · IEX Real-Time Price · USD
0.800
-0.140 (-14.94%)
At close: Jul 19, 2024, 4:00 PM
0.813
+0.012 (1.56%)
Pre-market: Jul 22, 2024, 7:47 AM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $189.21 thousand as of July 22, 2024. Its market cap has decreased by -5.40% in one year.
Market Cap
189.21K
Enterprise Value
-6.92M
1-Year Change
-5.40%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since December 7, 2015, Biodexa Pharmaceuticals's market cap has decreased from $492.00M to $189.21K, a decrease of -99.96%. That is a compound annual growth rate of -59.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 3.40M | 78.95% |
Dec 29, 2023 | 1.90M | -51.28% |
Dec 30, 2022 | 3.90M | -70.45% |
Dec 31, 2021 | 13.20M | 29.41% |
Dec 31, 2020 | 10.20M | 21.43% |
Dec 31, 2019 | 8.40M | -55.56% |
Dec 31, 2018 | 18.90M | -76.84% |
Dec 29, 2017 | 81.60M | -55.82% |
Dec 30, 2016 | 184.70M | -43.10% |
Dec 31, 2015 | 324.60M | -34.02% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Dermata Therapeutics | 1.20M |
Salarius Pharmaceuticals | 1.09M |
GRI Bio | 1.01M |
China SXT Pharmaceuticals | 793.36K |
Bluejay Diagnostics | 353.49K |